2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

How will the pharmaceutical landscape shape up in 2022? Industry experts share their predictions.

We find out more about the video game that won FDA approval as a treatment for children with ADHD

COVID-19 caused a shift in scientific research. But what happened to the research programs that existed before the pandemic hit?

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Changes are coming to Annex 1 of the EU’s GMP. What can pharma expect?

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.